OverviewSuggest Edit

Clinical Ink is a clinical trial technology company that develops electronic documents recording software for recording source data on mobile devices during clinical trials. It offers Capture, Engage, and Insight, patient engagement platforms that directly capture eSource data and documents and keep patients informed, involved and compliant throughout the duration of a clinical trial. Its customer base includes pharmaceutical and medical device companies, academic institutions, and CROs. The platforms are used in a range of therapeutic areas including CNS, infectious diseases, dermatology, gastroenterology, and virology.

TypePrivate
Founded2007
HQWinston-Salem, NC, US
Websiteclinicalink.com
Employee Ratings4.2

Latest Updates

Employees (est.) (Sept 2021)212(+9%)
Revenue (Y, 2015)$9 M(+53%)
Cybersecurity ratingAMore

Key People/Management at Clinical Ink

Ed Seguine

Ed Seguine

Chief Executive Officer, Board Member
Doug Pierce

Doug Pierce

President & Co-Founder
Scott Miltenberger

Scott Miltenberger

Chief Financial Officer
Vern Davenport

Vern Davenport

Board Member
Michael Sorensen

Michael Sorensen

Board Member
Chris Crucitti

Chris Crucitti

Chief Commercial Officer
Show more

Clinical Ink Office Locations

Clinical Ink has offices in Winston-Salem, Cambridge and Horsham
Winston-Salem, NC, US (HQ)
525 Vine St #130
Cambridge, MA, US
10 Canal Park
Horsham, PA, US
110 Gibraltar Rd #150
Show all (3)

Clinical Ink Financials and Metrics

Summary Metrics

Founding Date

2007

Clinical Ink total Funding

$35 m

Clinical Ink latest funding size

$5.3 m

Time since last funding

3 years ago

Clinical Ink investors

Clinical Ink's latest funding round in May 2018 was reported to be $5.3 m. In total, Clinical Ink has raised $35 m
Show all financial metrics

Clinical Ink Revenue

Clinical Ink's revenue was reported to be $9 m in Y, 2015 which is a 52.5% increase from the previous period.
USD

Revenue (Y, 2015)

9.0m

Revenue growth (Y, 2014 - Y, 2015), %

52.5%
USDY, 2014Y, 2015

Revenue

5.9m9.0m

Revenue growth, %

53%
Show all financial metrics

Clinical Ink Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

SecurityScorecard logo

Clinical Ink Online and Social Media Presence

Embed Graph

Clinical Ink News and Updates

GI Partners Completes Acquisition of Clinical Ink

SAN FRANCISCO, Aug. 26, 2020 /PRNewswire/ -- GI Partners, a leading private investment firm, announced today it has completed the previously announced acquisition of Clinical Ink, Inc., a global clinical trial technology company. Headquartered in Horsham, PA, Clinical Ink offers data...

Clinical Ink Blogs

Empowerment Model: A Model to Efficiently Build eCOA Clinical Trials

As pioneers in eSource, a technology that enables electronic data capture at its inception, we’re constantly looking for ways to streamline clinical trials and minimize the time it takes to launch them. By using our Lunexis™ eSource Ecosystem, our customers shave months off their timelin…

Clinical Ink CBO Jonathan Andrus Selected as DTRA Co-Leader Chosen to Head Decentralized Trials & Research Alliance Regulatory Gap Initiative

Horsham, Pa.; August 12, 2021 – Clinical Ink, a global clinical trial technology company, today announced that CBO Jonathan Andrus has been selected to co-lead the Decentralized Trials & Research Alliance’s (DTRA) Initiative 4B: Collaborate on Regulatory Gaps. Building on his extensive relations…

How Real-Time Data Can Expedite Infectious Disease Clinical Trials

For infectious disease studies of any kind, the ability to accelerate trial timelines, while also providing high-quality data and reducing barriers to patient participation, is highly prized. And when the World Health Organization (WHO) declares a virus a pandemic, there’s no time to los…

Clinical Ink Hires Industry Veteran Janette Morgan as General Manager, EMEA

New Role to Serve Rapidly Expanding Global Customer Base Horsham, Pa.; May 18, 2021 – Clinical Ink, a global clinical trial technology company, today announced the hiring of Janette Morgan as EVP, General Manager, EMEA. In this unique, hybrid role, Janette will manage the company’s dramatic global g…

Leveraging eSource Ecosystems for Improving Complex Neuropsychological Assessments: RBANS® Example

An Interview With Cogstate Neuropsychologist Robert McCue CNS clinical outcome assessment — particularly performance-based outcome measures — are among the most complex and nuanced assessments in clinical trials. This complexity's potential impact on data quality and signal detection in…

Clinical Ink Hires CCO Chris Crucitti, COO Brian Donahue, VP Bill Barrasso

New Positions Created to Manage Dramatic Growth HORSHAM, Pa.; May 4, 2021 – Clinical Ink, a global clinical trial technology company, today announced the hiring of CCO Chris Crucitti, COO Brian Donahue, and VP Project Operations Bill Barrasso. All three positions are newly created to help manage the…
Show more

Clinical Ink Frequently Asked Questions

  • When was Clinical Ink founded?

    Clinical Ink was founded in 2007.

  • Who are Clinical Ink key executives?

    Clinical Ink's key executives are Ed Seguine, Doug Pierce and Scott Miltenberger.

  • How many employees does Clinical Ink have?

    Clinical Ink has 212 employees.

  • What is Clinical Ink revenue?

    Latest Clinical Ink annual revenue is $9 m.

  • What is Clinical Ink revenue per employee?

    Latest Clinical Ink revenue per employee is $42.5 k.

  • Who are Clinical Ink competitors?

    Competitors of Clinical Ink include Arcadia Solutions, Quartesian and Biorasi.

  • Where is Clinical Ink headquarters?

    Clinical Ink headquarters is located at 525 Vine St #130, Winston-Salem.

  • Where are Clinical Ink offices?

    Clinical Ink has offices in Winston-Salem, Cambridge and Horsham.

  • How many offices does Clinical Ink have?

    Clinical Ink has 3 offices.